Signaling through Ras Is Essential for retOncogene-induced Cell Differentiation in PC12 Cells
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Specific germline mutations of the receptor tyrosine kinase, Ret, predispose to multiple endocrine neoplasia types 2A and 2B and familial medullary thyroid carcinoma. The mechanisms by which different Ret isoforms (Ret-2A and Ret-2B) cause distinct neoplastic diseases remain largely unknown. On the other hand, forced expression of these mutated versions of Ret induces the rat pheochromocytoma cell line, PC12, to differentiate. Here we used an inducible vector encoding a dominant-negative Ras (Ras p21(N17)) to investigate the contributions of the Ras pathway to the phenotype induced in PC12 cells by the expression of either Ret-2A or Ret-2B mutants. We show that the Ret-induced molecular and morphological changes are both mediated by Ras-dependent pathways. However, even though inhibition of Ras activity was sufficient to revert Ret-induced differentiation, the kinetics of morphological reversion of the Ret-2B- was more rapid than the Ret-2A-transfected cells. Further, we show that in Ret-transfected cells the suc1-associated neurotrophic factor-induced tyrosine phosphorylation target, SNT, is chronically phosphorylated in tyrosine residues, and associates with the Sos substrate. These results indicate the activation of the Ras cascade as an essential pathway triggered by the chronic active Ret mutants in PC12 cells. Moreover, our data indicate SNT as a substrate for both Ret mutants, which might mediate the activation of this cascade.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2 Ras is required for expression of Krox-24 and vgf genes and for ERK kinase activity. A , Northern blot analysis of total cellular RNA (20 m g/lane) obtained from PC12 and PC12 variant cells as indicated: parental PC12, either untreated or stimulated for 5 h with NGF (100 ng/ml) as indicated; PC12/MEN2A-cl.3 ( MEN2A ); PC12/MEN2A N17 -cl.R1 ( MEN2A N17 ); PC12/MEN2B-cl.7 ( MEN2B ); PC12/MEN2B N17 -cl.R2 ( MEN2B N17 ) were treated for 6 h either with vehicle ( 2 ) or with dexamethasone (0.5 m M) ( 1 ), as indicated ( DEX ). The same filters were hybridized with either a Krox-24 -specific or vgf -specific probe as indicated, and equal gel loading was confirmed with a ribosomal 18 S probe. B , the cells and the treatment were the same as in A (except for NGF stimulation that lasted for 10 min). The cell lysates were immunoprecipitated with anti-ERK-1 antibody and assayed for kinase activity as described under 'Experimental Procedures.' In each experiment we verified that the same amounts of ERK were used in the kinase assay. Proteins from each of the immunoprecipitates were separated on 11% SDS-PAGE and immunoblotted with the same anti-ERK-1 antibody. Immunoblots confirmed that the same amount of ERK was used in each kinase assay (data not shown). The results shown were typical and representative of two independent experiments. C , PC12 cells were transfected with p Krox-24 -CAT (2 m g) together with pRet9 C634Y (0.6 m g) or pRet9 M918T (0.6 m g). Where indicated, cells were also cotransfected with increasing amount of the pZipN17 expressing the Ras p21 N17 mutant. The inhibition, calculated as the difference between the CAT activity in the absence and in the presence of pZipN17, is plotted as percentage relative to the induction observed in the absence of pZipN17. Results were from a representative experiment, and they were confirmed in two independent experiments each performed in duplicate. D , PC12 variant cells were transfected with p vgf -CAT (2 m g) together with either the pBabe Ha-Ras or the pBabe vector (8 m g), as indicated. Where indicated, dexamethasone was added 5 h after transfection. Results are expressed as percentage of conversion to acetylated [ 14 C]chloramphenicol.](https://figures.cochat.ai/paper-figures/e091d8b3ce304a9ca633a6e4ed90242a/signaling-through-ras-is-essential-for-retoncogene-induced-cell-differentiation-figure-2.png)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The two prototype genes of Cluster 2 (RET and NF1) are linked by their common ability to activate the RAS/RAF/MAP kinase signaling cascade [16,17].”
From A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas (2005) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
Signaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway
Vossler, M. R., Yao, H., York, R. D., Pan, M.-G., Rim, C. S., & Stork, P. J. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80184-1 · Cited by 1,046
Intracellular Signaling Pathways Activated by Neuropathic Factors
Segal, R. A., & Greenberg, M. E. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.002335 · Cited by 951
Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., & Schlessinger, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80252-4 · Cited by 873
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H., et al. (1995) · Science · doi:10.1126/science.7824936 · Cited by 841
Self-citationHagag, N., Halegoua, S., & Viola, M. (1986) · Nature · doi:10.1038/319680a0 · Cited by 412
Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A Mutations
Asai, N., Iwashita, T., Matsuyama, M., & Takahashi, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1613 · Cited by 340
Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells.
Szeberényi, J., Cai, H., & Cooper, G. M. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.10.5324 · Cited by 322
Tsuzuki, T., Takahashi, M., Asai, N., Iwashita, T., Matsuyama, M., & Asai, J. (1995) · PubMed · Cited by 225
Klesse, L. J., Meyers, K. A., Marshall, C. J., & Parada, L. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202524 · Cited by 221
Feig, L. A., & Cooper, G. M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2472 · Cited by 213
Asai, N., Murakami, H., Iwashita, T., & Takahashi, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17644 · Cited by 184
Receptor tyrosine kinases and their targets
Kazlauskas, A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90085-x · Cited by 181
Tahira, T., Ishizaka, Y., Itoh, F., Sügimura, T., & Nagao, M. (1990) · PubMed · Cited by 180
Rabin, S. J., Cleghon, V, & Kaplan, D. R. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2203 · Cited by 173
Liu, X., Vega, Q. C., Decker, R. A., Pandey, A., Worby, C. A., & Dixon, J. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5309 · Cited by 160
Chiariello, M., Visconti, R., Carlomagno, F., Melillo, R. M., Bucci, C., de Franciscis, V., Fox, G. M., Jing, S., Coso, O. A., Gutkind, J. S., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201778 · Cited by 143
D'Arcangelo, G., & Halegoua, S. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3146 · Cited by 140
Michiels, F.-M., Chappuis, S., Caillou, B., Pasini, A., Talbot, M., Monier, R., Lenoir, G. M., Feunteun, J., & Billaud, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3330 · Cited by 140
RET activation by germline MEN2A and MEN2B mutations.
Borrello, M. G., Smith, D. P., Pasini, B., Bongarzone, I., Greco, A., Lorenzo, M. J., Arighi, E., Miranda, C., Eng, C., & Alberti, L. (1995) · PubMed · Cited by 134
Siegel, P. M., & Muller, W. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.8878 · Cited by 132
Lorenzo, M. J. V., Gish, G. D., Houghton, C., Stonehouse, T. J., Pawson, T. J., Ponder, B. A. J., & Smith, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1200894 · Cited by 132
Identification of Shc docking site on Ret tyrosine kinase
Arighi, E., Alberti, L., Torriti, F., Ghizzoni, S., Rizzetti, M. G., Pelicci, G., Pasini, B., Bongarzone, I., Piutti, C., Pierotti, M. A., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200896 · Cited by 127
Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras.
Jk, W., Xu, H., Hc, L., & Goldfarb, M. P. (1996) · PubMed · Cited by 117
van Weering, D. H. J., de Rooij, J., Marte, B., Downward, J., Bos, J. L., & Burgering, B. M. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1802 · Cited by 104
Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations
Rossel, M., Pasini, A., Chappius, S., Geneste, O., Fournier, L., Schuffenecker, I., Takahishi, M., van Grunsven, L. A., Urdiales, J. L., Rudkin, B. B., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1200831 · Cited by 89
Ret in human development and oncogenesis
Edery, P., Münnich, A., Lyonnet, S., & Eng, C. (1997) · BioEssays · doi:10.1002/bies.950190506 · Cited by 81
The GDNF Protein FamilyGene Ablation Studies Reveal What They Really Do and How
Rosenthal, A. (1999) · Neuron · doi:10.1016/s0896-6273(00)81077-6 · Cited by 80
Bocciardi, R., Mograbi, B., Pasini, B., Borrello, M. G., Pierotti, M. A., Bourget, I., Fischer, S., Romeo, G., & Rossi, B. (1997) · Oncogene · doi:10.1038/sj.onc.1201413 · Cited by 75
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation
Bongarzone, I., Viganò, E., Alberti, L., Borrello, M. G., Pasini, B., Greco, A., Mondellini, P., Smith, D. P., Ponder, B. A. J., Romeo, G., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201759 · Cited by 73
Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells.
van Weering, D. H. J., Medema, J. P., Puijenbroek, A. V., Burgering, B. M. T., Baas, P. D., & Bos, J. L. (1995) · PubMed · Cited by 66
Regulatory elements in the promoter region of vgf, a nerve growth factor-inducible gene.
Possenti, R., Rocco, G. D., Nasi, S., & Levi, A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3815 · Cited by 55
Smith, D. P., Eng, C., & Ponder, B. A. J. (1994) · Journal of Cell Science · doi:10.1242/jcs.1994.supplement_18.6 · Cited by 41
Califano, D., D'Alessio, A., Colucci-D'Amato, G. L., De Vita, G., Monaco, C., Santelli, G., Di Fiore, P. P., Vecchio, G., Fusco, A., Santoro, M., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7933 · Cited by 39
Self-citationColucci-D'Amato, G. L., D'Alessio, A., Califano, D., Calı̀, G., Rizzo, C., Nitsch, L., Santelli, G., & de Franciscis, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.25.19306 · Cited by 37
Self-citationActivated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells.
Califano, D., Monaco, C., Vita, G. D., D’Alessio, A. M., Dathan, N. A., Possenti, R., Vecchio, G., Fusco, A., Santoro, M. M., & de Franciscis, V. (1995) · PubMed · Cited by 36
Self-citationInherited cancers associated with the RET proto-oncogene
Goodfellow, P. J. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90034-5 · Cited by 25
Rizzo, C., Califano, D., Colucci‐D'Amato, G. L., Vita, G. D., D’Alessio, A., Dathan, N. A., Fusco, A., Monaco, C., Santelli, G., Vecchio, G., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29497 · Cited by 15
Self-citation
Research works printed but not linked: 12
- Tsuzuki, 1995, Oncogene, 10, 191
- Colucci-D' Amato, 1996, Cell Growth Diff., 7, 1081
- Borrello, 1995, Oncogene, 11, 2419
- D' Arcangelo, 1993, Mol. Cell. Biol., 13, 3146
- Califano, 1995, Oncogene, 11, 107
- D'Alessio, 1995, Cell Growth Diff., 6, 1387
- Tahira, 1990, Oncogene, 5, 97
- van Weering, 1995, Oncogene, 11, 2207
- Rabin, 1993, Mol. Cell. Biol., 13, 2203
- Wang, 1996, Oncogene, 13, 721
- Feig, 1988, Mol. Cell. Biol., 8, 2472
- Szeberenyi, 1990, Mol. Cell. Biol., 10, 5324
Cited by
The GDNF/RET signaling pathway and human diseases
Takahashi, M. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00012-0 · Cited by 446
“[103] Califano D, Rizzo C, D’Alessio A, Colucci-D’Amato GL, Calı̀ G, Bartoli PC, et al.”
BackgroundA HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas
Dahia, P. L. M., Ross, K. N., Wright, M. E., Hayashida, C. Y., Santagata, S., Barontini, M., Kung, A. L., Sanso, G., Powers, J. F., Tischler, A. S., et al. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010008 · Cited by 443
Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas
Welander, J., Söderkvist, P., & Gimm, O. (2011) · Endocrine-Related Cancer · doi:10.1530/erc-11-0170 · Cited by 355
“Oncogenic activation of RET triggers an activation of the RAS/RAF/MAPK pathway (Besset et al. 2000, Califano et al. 2000) and has also been associated with activation of the PI3K/AKT signaling pathway (Besset et al. 2000, Segouffin-Cariou & Billaud 2000).”
BackgroundNew Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
The RET proto-oncogene in human cancers
Jhiang, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203857 · Cited by 298
“Among these signaling pathways, signaling through Ras has been determined to be essential for RET-induced cell di erentiation in PC12 cells (Califano et al., 2000).”
Background
Metadata
- Authors
- Califano, D., Rizzo, C., D'Alessio, A., Colucci-D'Amato, G. L., Calı̀, G., Bartoli, P. C., Santelli, G., Vecchio, G., & de Franciscis, V.
- Affiliations
- Institute for Experimental Endocrinology and Oncology (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-06
- Volume
- 275
- Issue
- 25
- Pages
- 19297-19305
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2045078390
- Cited by
- 67
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 6 · 2014: 4 · 2013: 3 · 2012: 3
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7432 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, cc-by)
- Funders
- Fondazione Telethon
- Consiglio Nazionale delle Ricerche
- Associazione Italiana per la Ricerca sul Cancro
- National Institutes of Health (MD 20892)
- Fogarty International Center
- Center for Advanced Study, University of Illinois at Urbana-Champaign
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- RET receptor tyrosine kinase, Ras signaling, PC12 cells, neuronal differentiation, dominant negative Ras, multiple endocrine neoplasia type 2, medullary thyroid carcinoma, SO, tyrosine phosphorylation
- MeSH terms
- Animals, Cell Differentiation, Membrane Proteins, Neurons, Oncogenes, Phosphoproteins, Phosphorylation, Proto-Oncogene Proteins, Tyrosine, Signal Transduction, Oncogene Protein p21(ras), PC12 Cells, Receptor Protein-Tyrosine Kinases, Drosophila Proteins, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-ret, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.